Halal Pharmaceutical Ingredients: What Manufacturers and Importers Need to Know

Halal pharmaceutical compliance is one of the most complex and least understood areas of halal certification. Unlike food products, where the ingredient list is clearly visible on packaging, pharmaceutical formulations involve dozens of excipients — binding agents, capsule shells, coatings, stabilisers, and solubilisers — that may contain animal-derived or alcohol-based materials that render a product impermissible under Islamic law.

For manufacturers targeting Muslim-majority markets, and for importers supplying hospitals, pharmacies, and health ministries in countries such as Malaysia, Indonesia, and Saudi Arabia, understanding halal pharma requirements is no longer optional. Indonesia made halal certification mandatory for pharmaceuticals as part of its 2024 regulatory rollout. Malaysia's JAKIM has maintained a pharmaceutical certification track for over a decade. Saudi SFDA actively maintains a list of approved halal-certified medicines for import.

What Makes a Pharmaceutical Non-Halal?

The halal status of a pharmaceutical product is determined by examining both active pharmaceutical ingredients (APIs) and excipients across the full formulation. The most common sources of non-compliance are:

1. Gelatin

Gelatin is the single most widespread non-halal ingredient in pharmaceuticals. It is used as the shell material in hard and soft capsules, as a binding agent in tablets, and as a coating on gel-cap formulations. The majority of pharmaceutical-grade gelatin is derived from porcine (pig) sources — which is categorically prohibited in Islam — or bovine (cattle) sources, which require verification that the animal was slaughtered according to halal requirements.

Hard capsules are the most common delivery system in pharmaceuticals. Unless the manufacturer specifically uses halal-certified bovine gelatin, HPMC (hydroxypropyl methylcellulose) capsules, or pullulan capsules as alternatives, the product is almost certainly non-halal. Muslim patients and healthcare purchasers should not assume a capsule-based medication is halal without positive certification.

2. Porcine-Derived Excipients

Beyond gelatin, porcine derivatives appear in pharmaceutical formulations in less obvious forms:

• Lard (porcine fat) — historically used as a lubricant in tablet manufacturing; largely replaced in modern facilities but still present in older formulations
• Heparin — a widely used anticoagulant derived from porcine intestinal mucosa; no plant-based equivalent currently exists at pharmaceutical scale
• Pancreatin and pancrelipase — digestive enzyme supplements typically derived from porcine pancreas
• Stearic acid and magnesium stearate — common tablet lubricants that may be derived from animal (including porcine) fats, though plant-derived versions exist and are increasingly standard
• Lactose — a dairy-derived excipient used as a filler/diluent; halal-permissible in principle, but requires verification that the source dairy is halal-compliant

3. Alcohol (Ethanol)

Alcohol appears in pharmaceutical formulations as a solvent, preservative, and extraction medium. Liquid formulations — oral solutions, tinctures, cough syrups — are the most common concern, but alcohol is also present as a residual solvent in some solid dose forms and as a solubiliser in injectable formulations.

The halal status of pharmaceutical alcohol is the subject of ongoing scholarly debate. The consensus position among major certification bodies, including JAKIM and BPJPH, holds that:

• Ethanol derived from fermentation of grapes or dates for the purpose of producing alcohol is prohibited (najis mughallazah — heavily impure)
• Ethanol derived from industrial (non-food) sources and used at trace levels as a processing aid may be permissible under necessity (darura) if no halal alternative exists
• Products where alcohol is the primary active ingredient (e.g. traditional wine-based tonics) are not certifiable as halal
• For certification purposes, ethanol content must typically be below a defined threshold (commonly 0.5% w/v in finished product) and must be from non-khamr (non-intoxicant) sources

Manufacturers should document the source and concentration of any ethanol used in formulation. JAKIM's Technical Guide on Halal Pharmaceuticals (MS 2424) provides detailed guidance on acceptable ethanol limits and source verification requirements. Use the HalalExpo Ingredient Checker to screen common solvents and excipients.

4. Blood and Blood-Derived Products

Blood and its derivatives — including albumin, haemoglobin, and plasma proteins — are prohibited in Islam. While these are less common in standard pharmaceutical formulations, they appear in some biologics, wound care products, and cell culture media used in vaccine manufacturing. Manufacturers of biological products should audit their upstream production processes, not just the finished formulation.

Regulatory Requirements by Market

JAKIM (Malaysia) — MS 2424

JAKIM introduced MS 2424:2019, the Malaysian Standard for Halal Pharmaceuticals, which covers finished pharmaceutical products, active ingredients, and excipients. Key requirements include:

• All animal-derived ingredients must come from halal-slaughtered sources with auditable supply chain documentation
• Gelatin must be from halal-certified bovine sources or replaced with HPMC/pullulan alternatives
• Alcohol (ethanol) must be from non-khamr industrial sources and meet the concentration limits specified in MS 2424
• Manufacturers must submit full excipient declarations and Certificate of Analysis documents for each ingredient
• JAKIM conducts factory audits of ingredient suppliers, not just the finished product manufacturer

JAKIM halal certification for pharmaceuticals is not mandatory for all products sold in Malaysia, but it is increasingly required by government procurement, hospital formularies, and retail pharmacy chains targeting Muslim consumers. The Malaysian government's own drug procurement gives preference to halal-certified medicines where clinically equivalent alternatives exist.

BPJPH (Indonesia) — Mandatory from 2024

BPJPH issued implementing regulations under Indonesia's Halal Product Assurance Law (JPH Law No. 33/2014) that brought pharmaceuticals into scope for mandatory halal certification as of October 2024. This is the most significant regulatory development in halal pharma globally:

• All pharmaceutical products sold in Indonesia — domestic and imported — must carry BPJPH halal certification or declare themselves as non-halal (haram) on packaging
• Importers must work through BPJPH-accredited Halal Inspection Bodies (LPH) to obtain certification for foreign-manufactured products
• Transition periods apply for products already registered with BPOM (Indonesia's drug regulator); existing registration holders have a window to obtain halal certification before enforcement begins
• Pharmaceutical ingredients (excipients and APIs) produced or imported into Indonesia are also subject to halal certification under the full-scope rollout

For importers supplying the Indonesian market — the fourth most populous country in the world — this regulation has immediate commercial implications. Pharmaceutical distributors and wholesalers should audit their product portfolios now for BPJPH compliance gaps.

SFDA (Saudi Arabia)

The Saudi Food and Drug Authority (SFDA) maintains a register of approved pharmaceutical products for import and sale in Saudi Arabia. While SFDA does not operate its own halal certification scheme for pharmaceuticals in the same manner as JAKIM or BPJPH, its product registration process requires declaration of all ingredients and their sources.

• Porcine-derived ingredients are prohibited; manufacturers must provide alternatives or declare non-halal status (which significantly restricts market access)
• Heparin from porcine sources is a known point of scrutiny — manufacturers should be prepared to provide documentation and, where possible, source bovine heparin alternatives
• Saudi market practice gives strong preference to products certified by GCC-recognised halal bodies, including ESMA (UAE), SFDA-reviewed foreign bodies, and Islamic Development Bank-affiliated certifiers

Practical Steps for Manufacturers

If you are a pharmaceutical manufacturer seeking to enter halal markets or obtain halal certification, the following steps apply regardless of target market:

1. Full ingredient audit — document every ingredient in your formulation, including excipients, coatings, inks, and packaging materials. Identify all animal-derived and alcohol-derived inputs.
2. Supplier qualification — obtain Certificates of Origin, halal certificates, and Certificates of Analysis from each ingredient supplier. Certification bodies will audit your supply chain, not just your facility.
3. Formulation review — where porcine gelatin capsules are used, evaluate the cost of switching to HPMC or bovine halal-certified alternatives. For many oral solid dose forms, this is a straightforward substitution.
4. Alcohol documentation — document the source, grade, and concentration of any ethanol in your formulation. Obtain letters from your ethanol supplier confirming industrial (non-khamr) source.
5. Engage a certification body early — JAKIM, BPJPH-accredited LPHs, and other bodies offer pre-application consultations. Identify your target markets and work with the appropriate certifier from the outset to avoid reformulation costs at audit stage.

Special Cases: Vaccines and Biologics

Vaccines present a unique halal compliance challenge because many are manufactured using animal-derived cell culture media (including bovine serum and porcine-derived trypsin), and some formulations contain gelatin as a stabiliser. The halal status of vaccines has been the subject of specific fatwas from JAKIM, MUI (Indonesia), and Al-Azhar (Egypt).

The consensus scholarly position — adopted by JAKIM, MUI, and the Islamic Fiqh Academy of the OIC — holds that vaccines may be permissible under the principle of necessity (darura) even where animal-derived process aids are used, provided:

• The final product contains no detectable porcine or prohibited material (i.e., the manufacturing process transforms or removes the source material)
• No halal-equivalent alternative exists at equivalent efficacy and safety
• A recognised Islamic scholarly body has reviewed and issued a fatwa permitting the specific product

Manufacturers of vaccines targeting Muslim-majority markets should engage directly with the relevant national fatwa councils early in product registration, rather than relying on the general pharmaceutical halal standard.

Next Steps

Browse the full directory of halal certification bodies — including JAKIM, BPJPH, and SFDA — to find the right certifier for your target pharmaceutical market. Use the HalalExpo Ingredient Checker to screen excipients, solvents, and processing aids against known halal status data. For regulatory updates on mandatory halal certification rollouts, explore the HalalExpo news and analysis section.